EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMixed-Methods-StudieOpen Access

Digital Intervention for Electronic Patient-Reported Outcomes in Advanced Cancer: Mixed Methods Study

Christina Sauer iD, Simeon Sauer iD, Elena Sophia Doll iD, Stefanie Zschäbitz iD, Jan Simon Raue iD, Maik Turni iD, Till Johannes Bugaj iD, Kiriaki Hiller iD, Imad Maatouk iD

JMIR Cancer · 18.06.2026 · 12 · e91416-e91416

DOI: 10.2196/91416 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Cancer, online erschienen am 18.06.2026. Verfasst von Christina Sauer und 8 weiteren Autor:innen. Beteiligte Einrichtung: University Cancer Center Frankfurt (UCT), University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Hesse, 60590, Germany, 49…. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Neoplasms, Mobile Applications. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Digital health interventions are increasingly being integrated into oncological care to support patients in managing treatment-related symptoms and psychological distress. In a randomized controlled pilot trial, we investigated the feasibility and preliminary efficacy of a digital health app (SOFIA) among patients with cancer, including those in palliative care. SOFIA consists of an electronic patient-reported outcome (ePRO) assessment and coaching component. We showed good feasibility and high acceptability of SOFIA in routine clinical care.

Objective

This pilot study aimed to evaluate user experiences and behavior with SOFIA. We applied a mixed methods design, combining a qualitative exploration of patients’ experiences and a quantitative analysis of app usage patterns. The integrated findings are intended to inform the refinement and further development of digital health interventions to better address the needs, preferences, and engagement behaviors of this patient population.

Methods

Patients randomly assigned to the intervention group participated in semistructured interviews at 2 time points during the 12-week intervention period: midway through the intervention (at week 6) (T1) and postintervention (at week 12) (T2). Qualitative data were analyzed using content analysis. User data were descriptively analyzed with Python and the Pandas library (version 2.2.3).

Results

Our qualitative analysis of 29 patients revealed benefits regarding the ePRO assessment (empowerment, support, user-friendliness, and facilitation of patient-physician communication), as well as some criticism (inflexible design and insufficient use by physicians). Benefits of the coaching tool included the availability of helpful information and design aspects such as clarity and user-friendliness. Quantitative data from 32 active users of the app showed that 16 (50%) of patients read articles, 28 (87.5%) started journeys, and 15 (46.9%) completed exercises at any point during the study.

Conclusions

The results of this mixed methods study may provide important indications for digital interventions, including ePRO assessment, for patients with cancer. From the patients’ perspective, key features include intuitive design, relevant symptom items, reliable reminder functions, the translation of ePROs into clinically actionable information, clear symptom visualizations, seamless integration into electronic health records, and effective physician engagement. Both our qualitative and quantitative data show the importance of therapy-specific content. These results might increase acceptance and usage, and thereby also the clinical benefit, of future digital interventions for patients with cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Reported Outcome MeasuresNeoplasmsMobile ApplicationsHumansFemalePilot ProjectsMaleMiddle AgedDigital HealthAgedQualitative ResearchPalliative CareFeasibility StudiesAdult

Stichwörter der Autor:innen

cancerdigital interventioneHealthePROelectronic patient-reported outcomeimmune-checkpoint inhibitionimmunotherapy

Autor:innen und Institutionen

  • University Cancer Center Frankfurt (UCT), University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Hesse, 60590, Germany, 49 69-6301-83787, 49 69-6301-83788.
  • Technische Hochschule Mannheim, Mannheim, Baden-Wurttemberg, Germany.
  • Institute of Medical Psychology, University Hospital Heidelberg, Heidelberg, Baden-Wurttemberg, Germany.
  • Deptartment of Medical Oncology, University Hospital Heidelberg, Heidelberg, Baden-Wurttemberg, Germany.
  • Outcomes4Me Germany GmbH, Berlin, Berlin, Germany.
  • Department of General Internal Medicine, Psychosomatics and Psychotherapy, University Hospital Heidelberg, Heidelberg, Baden-Wurttemberg, Germany.

ORCID-Profile: Christina Sauer, Simeon Sauer, Elena Sophia Doll, Stefanie Zschäbitz, Jan Simon Raue, Maik Turni, Till Johannes Bugaj, Kiriaki Hiller, Imad Maatouk

Zitieren

APA

Sauer, C., Sauer, S., Doll, E. S., Zschäbitz, S., Raue, J. S., Turni, M., Bugaj, T. J., Hiller, K., & Maatouk, I. (2026). Digital Intervention for Electronic Patient-Reported Outcomes in Advanced Cancer: Mixed Methods Study. JMIR Cancer, 12, e91416-e91416. https://doi.org/10.2196/91416

Vancouver

Sauer C, Sauer S, Doll ES, Zschäbitz S, Raue JS, Turni M, et al. Digital Intervention for Electronic Patient-Reported Outcomes in Advanced Cancer: Mixed Methods Study. JMIR Cancer. 2026;12:e91416-e91416. doi:10.2196/91416

BibTeX
@article{Sauer2026,
  author = {Sauer, Christina and Sauer, Simeon and Doll, Elena Sophia and Zschäbitz, Stefanie and Raue, Jan Simon and Turni, Maik and Bugaj, Till Johannes and Hiller, Kiriaki and Maatouk, Imad},
  title = {Digital Intervention for Electronic Patient-Reported Outcomes in Advanced Cancer: Mixed Methods Study},
  journal = {JMIR Cancer},
  year = {2026},
  volume = {12},
  pages = {e91416--e91416},
  doi = {10.2196/91416}
}
Kostenlos starten →